Package Leaflet: Information for the user Laxido Paediatric Plain 6.9 g, powder for oral solution

Similar documents
Package leaflet: Information for the user. Compound Macrogol Oral Powder Sugar Free

If you need the information on this leaflet in an alternative format, such as large text, or Braille please ring from the UK:

Patient Information Leaflet MOVICOL Paediatric Plain 6.9g sachet, powder for oral solution

Package leaflet: Information for the user

Package Leaflet: Information for the patient. Movicol Ready to Take oral solution in sachet

Read all of this leaflet carefully before you start taking this medicine

Package Leaflet: Information for the User

Package leaflet: Information for the user. Omnilax 10 g powder for oral solution, sachet. Macrogol 4000

Package leaflet: Information for the user. <PRODUCT NAME> 10 g powder for oral solution in sachet Macrogol 4000

Package leaflet: Information for the user. Ursodeoxycholic Acid Capsules 250mg (Ursodeoxycholic acid)

Package leaflet: Information for the user. Ursodeoxycholic Acid Tablets 150mg (Ursodeoxycholic acid)

Package leaflet: Information for the User. Moviprep Orange, powder for oral solution

Package leaflet: Information for the user. Co-Codamol 30mg/500mg Capsules (Codeine Phosphate Hemihydrate and Paracetamol)

Plenvu powder for oral solution Macrogol 3350, sodium ascorbate, sodium sulfate anhydrous, ascorbic acid, sodium chloride and potassium chloride.

Package leaflet: Information for the user. SenEase 7.5 mg tablets. Sennosides

Package leaflet: Information for the patient

PACKAGE LEAFLET: INFORMATION FOR THE USER

Package leaflet: Information for the patient. Moventig 12.5 mg film-coated tablets Moventig 25 mg film-coated tablets. naloxegol

Package leaflet: Information for the patient. NEGABAN 1g, powder for solution for injection or infusion Temocillin

Package leaflet: Information for the user Zinforo 600 mg powder for concentrate for solution for infusion Ceftaroline fosamil

Package leaflet: Information for the user. Cefixime ABR 100 mg/5 ml powder for oral suspension Cefixime

Package leaflet: Information for the patient. Bumetanide 1 mg and 5 mg Tablets (bumetanide)

Imodium 1 mg/5 ml oral solution

RABEPRAZOL 10mg and 20mg Gastro-resistant Tablets

PACKAGE LEAFLET: INFORMATION FOR THE USER

PACKAGE LEAFLET: INFORMATION FOR THE USER. DUKORAL suspension and effervescent granules for oral suspension Cholera vaccine (inactivated, oral)

PACKAGE LEAFLET: INFORMATION FOR THE USER. DF118 Tablets 30mg (Dihydrocodeine Hydrogen Tartrate)

Some general information on hepatitis A infection is given at the end of this leaflet.

Package leaflet: Information for the patient

THORENS I.U. /ml oral drops, solution Cholecalciferol (vitamin D 3 )

PACKAGE LEAFLET: INFORMATION FOR THE USER. Dantrium 25 mg Capsules / Dantrium 100 mg Capsules Dantrolene sodium

PACKAGE LEAFLET: INFORMATION FOR THE USER. PEGLAX 10g Powder for oral solution in sachet. Macrogol 4000

Package Leaflet: Information for the Patient. FOSRENOL 750 mg oral powder. FOSRENOL 1000 mg oral powder. lanthanum

Package leaflet: Information for the user. Dalmevin 50 mg tablets Vildagliptin

Package leaflet: Information for the user. Ebateva 20 mg Orodispersible Tablets. Ebastine

PACKAGE LEAFLET: INFORMATION FOR THE USER. SALAGEN 5 mg film-coated tablets. Pilocarpine hydrochloride

PACKAGE LEAFLET DIASTABOL 50 MG TABLETS. Version 1.0 1

PACKAGE LEAFLET: INFORMATION FOR THE USER Nicorandil 10 mg Tablets Nicorandil 20 mg Tablets nicorandil

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. Estracyt Capsules Estramustine phosphate 140mg (as estramustine sodium phosphate)

Package leaflet: Information for the patient. Velphoro 500 mg chewable tablets Iron as sucroferric oxyhydroxide

Package leaflet: Information for the patient. Vertigon 8 mg Tablets Vertigon 16 mg Tablets (betahistine dihydrochloride)

PACKAGE LEAFLET: INFORMATION FOR THE USER. XIFAXANTA 200 mg film-coated tablets Rifaximin

Package leaflet: Information for the patient. Calcium Folinate 15 mg Tablets calcium folinate

Package Leaflet: Information for the Patient. FOSRENOL 750 mg chewable tablets. FOSRENOL 1000 mg chewable tablets. lanthanum

Package leaflet: Information for the patient. Lymelysal 300 mg hard capsules. lymecycline equivalent to 300 mg tetracycline

Package leaflet: Information for the patient. Loratadine 10 mg Tablets (loratadine)

Package leaflet: Information for the patient

Motens 2 mg and 4 mg Tablets lacidipine

Package leaflet: Information for the user. Fleet Phospho-soda 24.4 g / 10.8 g oral solution

Package leaflet: Information for users. Imodium 2 mg orodispersible tablets Loperamide hydrochloride

Package leaflet: Information for the user

Package leaflet: Information for the user. Lycimor 300 mg Hard Capsules Lymecycline (equivalent to 300mg of tetracycline base)

1. What Miacalcic is and what it is used for

Package leaflet: Information for the user. Resolor 1 mg film-coated tablets Resolor 2 mg film-coated tablets prucalopride

Package leaflet: Information for the user. Salofalk 3g gastro-resistant prolonged-release granules. Mesalazine

PACKAGE LEAFLET: INFORMATION FOR THE USER. Bydureon 2 mg powder and solvent for prolonged-release suspension for injection in pre-filled pen exenatide

Package leaflet: Information for the user

PACKAGE LEAFLET: INFORMATION FOR THE USER

Package leaflet: Information for the user. Elaprase 2 mg/ml concentrate for solution for infusion idursulfase

Package leaflet: Information for the user

Package leaflet: Information for the user Salofalk 500mg gastro-resistant tablets Mesalazine

Package leaflet: Information for the user. Exembol 1 mg/ml solution for infusion. argatroban monohydrate

Package leaflet: Information for the patient. Zerbaxa 1 g / 0.5 g powder for concentrate for solution for infusion ceftolozane / tazobactam

PACKAGE LEAFLET: INFORMATION FOR THE USER. Anastrozole 1 mg film-coated tablets

Package Leaflet: Information for the user. Methocarbamol 750mg Film-Coated Tablets

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. ILAXTEN 20 MG TABLETS bilastine

Package leaflet: Information for the patient. Destolit 150 mg tablets Ursodeoxycholic acid

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT

PACKAGE LEAFLET: INFORMATION FOR THE USER AMITIZA 24 MICROGRAM SOFT CAPSULES. Lubiprostone

Package leaflet: Information for the patient. Histaclar 10 mg Film-coated Tablets loratadine

PACKAGE LEAFLET: INFORMATION FOR THE USER RENNIE DUAL ACTION TABLETS. Calcium carbonate, Magnesium carbonate, Alginic acid Chewable tablets

Ventolin Injection 500 micrograms/ml salbutamol sulfate

Package leaflet: Information for the user. DaunoXome Injection 2mg/ml Concentrate for Solution for Infusion Daunorubicin

PACKAGE LEAFLET: INFORMATION FOR THE USER. Folic Acid 2.5mg/5ml Oral Solution Folic Acid 2.5mg/5ml

Package leaflet: Information for the user. Flutamid Stada 250 mg tablets Flutamide

PRED FORTE 1% w/v Eye Drops, Suspension Prednisolone acetate

PACKAGE LEAFLET: INFORMATION FOR THE USER Meronem IV 500 mg and 1 g Powder for solution for injection or infusion meropenem

Package leaflet: Information for the user Oftaquix 5 mg/ml eye drops, solution. Levofloxacin

PACKAGE LEAFLET: INFORMATION FOR THE USER. BritLofex Tablets 0.2mg LOFEXIDINE HYDROCHLORIDE

Package leaflet: Information for the user. Raxone 150 mg film-coated tablets idebenone

THORENS I.U. /2.5 ml oral solution. Cholecalciferol (vitamin D 3 )

PACKAGE LEAFLET: INFORMATION FOR THE USER. EASOFEN MAX STRENGTH 400mg FILM-COATED TABLETS. Ibuprofen

Package leaflet: Information for the patient. / / 30 mg/5 ml syrup. Ambroxol hydrochloride

Package leaflet: Information for the user. Bupivacaine 0.25% w/v, 0.5% w/v solution for injection Bupivacaine Hydrochloride

SUMMARY OF PRODUCT CHARACTERISTICS

Patient Information Leaflet Lodine* SR Tablets 600mg (etodolac) 1. WHAT LODINE SR TABLETS ARE AND WHAT THEY ARE USED FOR

Package leaflet: Information for the patient. Onglyza 2.5 mg film-coated tablets Onglyza 5 mg film-coated tablets Saxagliptin

Package leaflet: Information for the user. Pharmalgen Bee Venom Pharmalgen Wasp Venom. 100μg/ml. powder and solvent for solution for injection

Package leaflet: Information for the user. Colecalciferol 3000 IU/ml Oral Solution (colecalciferol)

Package leaflet: Information for the patient. Olumiant 2 mg film-coated tablets Olumiant 4 mg film-coated tablets Baricitinib

Dulcolax 5 mg, film-coated tablets

RELISTOR. Methylnaltrexone bromide, Subcutaneous solution for injection. Consumer Medicine Information

Package leaflet: Information for the user. Bricanyl Respules 2.5 mg/ml Nebuliser Solution terbutaline sulfate

PACKAGE LEAFLET: INFORMATION FOR THE USER. <PRODUCT NAME> 600 mg / 1,000 IU orodispersible tablets. Calcium/cholecalciferol (Vitamin D3)

Package leaflet: Information for the patient. Risedronate sodium 35 mg film-coated tablets. Risedronate sodium

Package leaflet: Information for the patient

1. What Octostim Nasal Spray is and what it is used for

Package Leaflet: Information for the User

Package leaflet: Information for the patient

Transcription:

Package Leaflet: Information for the user Laxido Paediatric Plain 6.9 g, powder for oral solution Read all of this leaflet carefully before you give this medicine to your child because it contains important information for you. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask the doctor, pharmacist or nurse. - This medicine has been prescribed for your child. Do not pass it on to others. It may harm them, even if their signs of illness are the same as your child s. - If your child gets any side effects, talk to their doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. - What is in this leaflet 1. What Laxido Paediatric Plain is and what it is used for 2. What you need to know before you give Laxido Paediatric Plain 3. How to give Laxido Paediatric Plain 4. Possible side effects 5. How to store Laxido Paediatric Plain 6. Contents of the pack and other information 1. What Laxido Paediatric Plain is and what it is used for Laxido Paediatric Plain contains macrogol 3350 and the electrolytes sodium chloride, sodium hydrogen carbonate and potassium chloride. Laxido Paediatric Plain is a laxative used for the treatment of chronic constipation in children aged 2 to 11 years. It is also used to treat a build up of hard faeces in the bowel in children aged 5 to 11 years, which may be a result of long-term constipation (this is known as faecal impaction). Macrogol 3350 makes your child s faeces softer and easier to pass, giving them relief from constipation. The electrolytes help to maintain the body s normal levels of sodium, potassium and water while your child is being treated for constipation. 2. What you need to know before you give Laxido Paediatric Plain Do not give Laxido Paediatric Plain if your doctor has told you that your child: - is allergic to macrogol 3350, sodium chloride, sodium hydrogen carbonate or potassium chloride - has a perforation in the wall of their intestine - has a blockage in their intestine - has paralysis of the intestine (for example, your child s intestines may stop working due to intestinal surgery or severe infection) - has ulcerative colitis, Crohn s disease or toxic megacolon. If any of these applies to your child, please talk to their doctor or pharmacist for further advice. 1.3.1 Package Leaflet 1

Warnings and precautions Before giving Laxido Paediatric Plain to your child for faecal impaction, it should be confirmed by their doctor that your child has this condition. If your child has a heart or kidney problem, an impaired gag reflex, reflux oesophagitis (heartburn caused by back-flow of stomach contents in the oesophagus) or reduced consciousness, you should talk to their doctor before giving Laxido Paediatric Plain. When taking Laxido Paediatric Plain you should continue to take plenty of fluids. The fluid content of Laxido Paediatric Plain should not replace your regular liquid intake. Other medicines and Laxido Paediatric Plain Tell their doctor or pharmacist if your child is taking, has recently taken, or might take any other medicines. Some medicines, e.g. anti-epileptics, may not work as effectively if they are taken at the same time as Laxido Paediatric Plain. When taking large volumes of Laxido Paediatric Plain (e.g. for faecal impaction), your child should not take other medicines within one hour of taking Laxido Paediatric Plain. Laxido Paediatric Plain with food, drink and alcohol Food and drink have no influence on the effect of Laxido Paediatric Plain. Pregnancy, breast-feeding and fertility Laxido Paediatric Plain can be given during pregnancy and whilst breast-feeding. Ask your pharmacist or doctor for advice before giving Laxido Paediatric Plain. Driving and using machines Laxido Paediatric Plain has no effect on the ability to drive or use machinery. Laxido Paediatric Plain contains sodium This medicinal product contains 4.06 mmol (or 93 mg) of sodium per sachet. This should be taken into consideration if your child is on a controlled sodium diet. 3. How to give Laxido Paediatric Plain Always give Laxido Paediatric Plain exactly as the doctor or pharmacist has told you. Check with the doctor or pharmacist if you are not sure. Laxido Paediatric Plain should be taken orally. Chronic constipation The recommended dose for chronic constipation depends on the age of the child and their response to treatment. - As a starting dose, children aged 2 to 6 years should be given 1 sachet each day and children aged 7 to 11 years should be given 2 sachets each day. - The doctor may tell you to increase the number of sachets taken until your child has a soft bowel movement. - If the dose does need increasing, this should be done every other day. Normally, no more than 4 sachets are required to be taken in one day. 1.3.1 Package Leaflet 2

It is not necessary to take all of the drink at one time, if the child prefers it, half the drink can be taken in the morning and half in the evening. Faecal impaction A course of treatment with Laxido Paediatric Plain is as follows: Number of Laxido Paediatric Plain sachets Age Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 (years) 5 to 11 4 6 8 10 12 12 12 The daily number of sachets should be taken in divided doses, all taken within 12 hours (e.g. 8am to 8pm). Treatment can be stopped when the medicine has worked. This is shown by your child passing large volumes of stool and/or watery diarrhoea. How to mix Laxido Paediatric Plain should be made up by dissolving the contents of one sachet in a quarter glass of water (62.5 ml). Stir well until all the powder has dissolved and the Laxido Paediatric Plain solution is clear or slightly hazy, then give it to your child to drink. If you like you can add a flavour such as orange squash to the drink. If your child is taking Laxido Paediatric Plain for faecal impaction it may be easier to dissolve 12 sachets in 750 ml of water. In this case, the reconstituted solution must be stored in accordance with the relevant instructions provided in section 5. Duration of treatment Chronic constipation The course of treatment for chronic constipation needs to be for a prolonged period of time, at least 6 to 12 months. Faecal impaction The course of treatment for faecal impaction can be for up to 7 days. If your child takes more Laxido Paediatric Plain than they should Your child may experience severe pains and swelling in their abdomen, or vomiting or diarrhoea. If this happens, contact their doctor or pharmacist. If you forget to give Laxido Paediatric Plain If you forget to give your child a dose, give it as soon as you remember and then continue on as before. Do not give a double dose to make up for a forgotten dose. If you stop giving Laxido Paediatric Plain To get the most benefit from Laxido Paediatric Plain, always make sure that your child finishes the course of treatment recommended by their doctor, pharmacist or nurse. This will make sure that your child s constipation is cleared, otherwise the symptoms they are suffering from may persist. If you have any further questions on the use of this medicine, ask the doctor, pharmacist or nurse. 1.3.1 Package Leaflet 3

4. Possible side effects Like all medicines, this medicine can cause side effects, although not everybody gets them. If your child experiences any of the following side effects, stop giving Laxido Paediatric Plain and see their doctor immediately: - signs of a serious allergic reaction, such as difficulty in breathing, or swelling of the face, lips, tongue or throat - signs of an allergy, such as a rash, reddening of the skin, nettle rash, itching or shortness of breath - signs of a change in the fluid or electrolyte levels in your child s body, such as swelling (mainly in the ankles), feeling fatigued, dehydration or increased thirst with headache. These symptoms may be a sign that the potassium levels in your child s blood are higher or lower than normal. The following side effects are most common: - abdominal pain - stomach rumbling - diarrhoea - vomiting - nausea - soreness of the anus (bottom) If your child is being treated for chronic constipation, diarrhoea will usually improve when the dose is reduced. The following side effects are less common: - swelling of your child s abdomen - suffering from wind - indigestion Reporting of side effects If your child gets any side effects, talk to their doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine. 5. How to store Laxido Paediatric Plain Keep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the carton and sachet. The expiry date refers to the last day of that month. You should store unopened sachets below 25 C. 1.3.1 Package Leaflet 4

Reconstituted Laxido Paediatric Plain solution can be covered and stored in the refrigerator (2 C to 8 C), and should be used within 24 hours. After 24 hours, any unused solution should be discarded. Do not use this medicine if you notice that any of the sachets are damaged. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment. 6. Contents of the pack and other information What Laxido Paediatric Plain contains The active substances in each sachet are macrogol 3350 (6.563 g), sodium chloride (175.4 mg), sodium hydrogen carbonate (89.3 mg) and potassium chloride (25.1 mg). Laxido Paediatric Plain does not contain any other ingredients. It does not contain any colours, flavours or sweeteners. What Laxido Paediatric Plain looks like and contents of the pack Laxido Paediatric Plain is a white powder for oral solution that is packed in sachets. Each sachet contains 6.9 g of powder and is packed in cartons containing 2, 6, 8, 10, 20, 30, 50 and 100 sachets. Not all of these pack sizes are marketed. Marketing Authorisation Holder Galen Limited Seagoe Industrial Estate Craigavon BT63 5UA UK Manufacturer Almac Pharma Services Limited Almac House 20 Seagoe Industrial Estate Craigavon BT63 5QD UK This medicinal product is authorised in the Member States of the EEA under the following names: Germany, Ireland and UK Laxido Paediatric Plain Portugal Laxido Mini Belgium and Luxembourg Laxido Junior Neutral Sweden Laxido Junior This leaflet was last revised in July 2017. 1.3.1 Package Leaflet 5